50-24-8 (泼尼松龙,Prednisolone)

泼尼松龙;11β,17α,21-三羟基孕甾-1,4-二烯-3,20-二酮;强的松龙;脱氢皮醇;孕甾-1,4-二烯-11β,17α,21-三醇-3,20-二酮;氢化泼尼松;去氢氢化可的松;泼尼松龙原粉;(+)-3-羧基-2,2,5,5-四甲基吡咯烷基-1-醇;* 泼尼松龙;Prednisolone 泼尼松龙 标准品;醋酸氢化泼尼松;甲醇中泼尼松龙溶液标准物质;泼尼松龙 USP标准品;泼尼松龙 强的松龙;泼尼松龙,USP, EP, BP;泼尼松龙标准品;泼尼松龙标准品(JP);强的松;强的松龙行情;盐酸多巴胺出厂;DRBC培养基;11Beta,17Alpha,21-三羟基孕甾-1,4-二烯-3,20-二酮;1-去氢皮质醇;醋酸泼尼松龙杂质B(EP) 标准品;甲基泼尼松龙杂质K(EP);氢化可的松杂质A(EP);氢化泼尼松 标准品;1,4-孕甾二烯-11β,17α,21-三醇-3,20-二酮;11β,17α,21-三羟基-1,4-孕甾二烯-3,20-二酮;1-去氢氢化可的松;氢化强的松;氢泼尼松;泼尼松龙 氢化泼尼松;醋酸泼尼松龙;

prednisolone;11-beta,17-alpha,21-trihydroxypregna-1,4-diene-3,20-dione;Prednisolone Solution;11,17,21-Trihydroxypregna-1,4-diene-3,20-dione;PREDNISOLONE(RG);prednisolone base;1,4-Pregnadiene-11b,17a,21-triol-3,20-dione;1,4-Pregnadiene-11β,17α,21-triol-3,20-dione;11beta,17alpha,21-Trihydroxypregna-1,4-diene-3,20-dione;deltaf;dicortol;eazolind;hydeltra;prednis;predonin;solone;steran;STEROLONE;ulacort;Metacortandralone;Hydroretrocortine;Predonine;Meticortelone;Deltacortril;Deltahydrocortisone;Prenolone;Hydroretrocortin;Delta-Cortef;PRDL;Hydrodeltalone;Hydrodeltisone;Deltacortenol;Prednelan;Precortancyl;Paracotol;Lentosone;Dydeltrone;Delcortol;Decaprednil;Predniliderm;Fernisolone;Donisolone;Cortalone;Scherisolon;Rolisone;Hydeltrone;Estilsona;Codelcortone;Prednicen;Precortisyl;Precortilon;Paracortol;Erbasona;Erbacort;Deltisilone;Cotogesi;Meti Derm;Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11.beta.)-;HMS3259E09;Opredsone;s1737;C07369;Prestwick_404;Eazolin D;Prednisolona;NC00473;NCGC00094764-01;Meti-Derm;Delta-Cortef (TN);GTPL2866;component of Ataraxoid;Prednisolone [BAN:INN:JAN];PREDNISOLONE (USP-RS);BDBM19190;HY-17463;NSC-9120;EC 200-021-7;11,17,21-Trihydroxypregna-1,4-diene-3,20-dione, (11.beta.)-;VETSOLONE;Linola-H N;Ultracorten H;Cotolone;PREDNISOLONE (USP MONOGRAPH);Prednisolone (JP17/USP/INN);delta(sup 1)-Dehydrohydrocortisone;Prestwick3_000274;Deltidrosol;(1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-1-(2-hydroxyacetyl)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one;NSC 9120;Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-;UNII-9PHQ9Y1OLM;Ultracortene-hydrogen;11-.beta.,17-.alpha.,21-Trihydroxy-1,4-pregnadiene-3,20-dione;prednisolon;BRD-K98039984-001-03-0;SR-01000837502-2;BPBio1_000164;Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-;Delta(1)Hydrocortisone;Pregna-1,20-dione, 11,17,21-trihydroxy-, (11.beta.)-;Prednisolona [INN-Spanish];MLS002548883;delta-dehydrocortisol;Prednisolonum;Cotogesic;LMST02030179;11.BETA.,17,21-TRIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE.;Prednisolone, >=99%;Tox21_111327_1;HYDROCORTISONE IMPURITY A (EP IMPURITY);D91990;Sterane;DTXSID9021184;(11-beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione;Prednisolone (injectable liposome formulation, rheumatoid arthritis), Galapagos;1,4-Pregnadiene-11-.beta.,17-.alpha.,21-triol-3,20-dione;PREDNISOLONE [EP];HMS2090J05;Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-;METHYLPREDNISOLONE IMPURITY K [EP IMPURITY];Prednisolone, British Pharmacopoeia (BP) Assay Standard;PREDNISOLONE [USP MONOGRAPH];PREDNISOLONE [MI];delta(1)-Hydrocortisone;.delta.-Stab;delta(sup 1)-Dehydrocortisol;Delta-F;PREDNISONE IMPURITY B;Predni-Helvacort;NCGC00179649-01;SMR000718761;Delta(1)-dehydrohydrocortisone;MLS002638110;Delta F;component of K-Predne-Dome;DB00860;CHEMBL131;Prednisolone, Pharmaceutical Secondary Standard; Certified Reference Material;Prestwick0_000274;.DELTA.1-Hydrocortisone;.DELTA.(sup 1)-Dehydrohydrocortisone;PREDNISOLONE [VANDF];NCGC00179649-02;PREDNISOLONE [ORANGE BOOK];Tox21_302987;(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-8,10,13-trimethyl-3-oxo-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxylic acid;Prednisolone;delta-dehydrohydrocortisone;MLS001304083;11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione;AC-1773;PREDNISOLONE [HSDB];11beta,17,21-trihydroxy-1,4-pregnadiene-3,20-dione;PREGNA-1,4-DIENE-3,20-DIONE, 11,17,21-TRIHYDROXY-, (11.BETA)-;EN300-53017;Linola-H-Fett N;SPBio_002367;Supercortisol;HMS2095H10;MLS002207037;CO-Hydeltra;4-08-00-03467 (Beilstein Handbook Reference);delta1-Hydrocortisone;PREDNISOLONE [JAN];Bubbli-Pred;Neo-Delta-Cortef;1,4-Pregnadien-11-beta,17-alpha,21-triol-3,20-dione;PREDNICARBATE IMPURITY A (EP IMPURITY);Predni-Coelin;Pred-Clysma;Frisolona;Dacortin H;PREDNISOLONE (EP MONOGRAPH);1-Dehydrohydrocortisone;Di-Adreson-F;delta-hydrocortisone;.DELTA.1-Cortisol;PREDNISONE IMPURITY B [EP];Gupisone;Longiprednil;11-.beta.,17,21-Trihydroxypregna-1,4-diene-3,20-dione;Decortin H;SR-01000837502;Capsoid;Prestwick2_000274;NCGC00256577-01;(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one;K 1557;BCP09053;Prenilone;AKOS015894935;CCG-220274;NSC9900;NCGC00179649-03;'(11alpha)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione';AS-13665;PREDNISOLONE [WHO-IP];Kuhlprednon;Prednisolone for peak identification, European Pharmacopoeia (EP) Reference Standard;Derpo PD;Tox21_201673;delta-1-dehydrohydrocortisone;Fernisolone P;HMS1568H10;Lepi-Cortinolo;Delta1-dehydro-hydrocortisone;PREDNISOLONE [WHO-DD];.DELTA.(sup 1)-Cortisol;Prednisolone (injectable liposome formulation, rheumatoid arthritis);Hostacortin H;Prednisolone [INN:BAN:JAN];MFCD00003649;HMS2230P10;Prednisolone (injectable liposome formulation, rheumatoid arthritis), Enceladus;Delta-Diona;Nanocort;delta-1-Cortisol; Prednicarbate EP Imp A; Supercortisol;Prednisolone (anhydrous);1,4-Pregnadiene-11-beta,17-alpha,21-triol-3,20-dione;PREDNISOLONE [EP MONOGRAPH];D00472;EQUISOLON;(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one;Predate;D0D1SG;11-beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione;1,4-pregnadiene-3,20-dione-11beta,17-alpha,21-triol;Prednisolone, VETRANAL(TM), analytical standard;Adnisolone;9PHQ9Y1OLM;APREDNISLON;delta(1)-Dehydrocortisol;Pregna-1,4-diene-3,20-dione, 11.beta.,17,21-trihydroxy-;Cordrol;3,20-Dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene;1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol;11-.beta.,17-.alpha.,21-Trihydroxypregna-1,4-diene-3,20-dione;delta-1-hydrocortisone;PREDNISOLONE ACETATE IMPURITY B [EP IMPURITY];NCGC00179649-06;Dontisolon D;Delta-Ef-Cortelan;Q11426176;DELTA.1-Cortisol;PREDNISOLONE [MART.];Panafcortelone;delta(1)-Cortisol;PREDNISOLONE [INN];Prednisolone, United States Pharmacopeia (USP) Reference Standard;CAS-50-24-8;Fernisolone-P;Dhasolone;Prednisolone, European Pharmacopoeia (EP) Reference Standard;.DELTA.1-Dehydrocortisol;PREDNICARBATE IMPURITY A [EP IMPURITY];1,4-Pregnadien-11-.beta.,17-.alpha.,21-triol-3,20-dione;BSPBio_000148;Predisolone Sodium Phosphate;8056-11-9;1,4-Pregnadiene-3,20-dione-11-.beta.,17-.alpha.,21-triol;Prelone;DTXCID301184;MLS002154250;1,4-Pregnadiene-3,20-dione-11-beta,17-alpha,21-triol;Fisopred;50-24-8;T-Pred (Salt/Mix);Predniretard;CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE;delta-1-dehydrocortisol;K-Predne-Dome (Salt/Mix);PREDNISOLONE (EMA EPAR: VETERINARY);PREDNISOLONE (MART.);Predne-Dome;delta(sup 1)-Cortisol;CHEBI:8378;PREDNISOLONE [USP-RS];1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione;Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-;Predeltilone;Prednisolone Powder;Prednisolone for system suitability, European Pharmacopoeia (EP) Reference Standard;Lenisolone;.DELTA.(sup 1)-Hydrocortisone;A929791;.delta.-Cortef;LS-7669;(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione;PREDNISOLONE ANHYDROUS;PREDNISOLONE COMPONENT OF CHLOROPTIC-P S.O.P.;Preflam;Prednisolonum [INN-Latin];(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one;PREDNISOLONUM [WHO-IP LATIN];NSC9120;CCRIS 980;NCGC00179649-04;BRD-K98039984-001-06-3;Prestwick1_000274;Delta-Phoricol;Dexa-Cortidelt hostacortin H;Q-201616;(+)-PREDNISOLONE;.DELTA.1-Dehydrohydrocortisone;delta(sup 1)-Hydrocortisone;Prednicortelone;Z778141968;Tox21_111327;NCGC00259222-01;METHYLPREDNISOLONE IMPURITY K (EP IMPURITY);SCHEMBL3233;PREDNISOLONE [GREEN BOOK];BRN 1354103;Deltasolone;1,2-Dehydrohydrocortisone;Delta-stab;HMS3712H10;Di-adreson F;Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11b)-;TUA;HSDB 3385;NSC-9900;Ultracortene-H;Klismacort;EINECS 200-021-7;.DELTA.(sup 1)-Dehydrocortisol;11.beta.,17.alpha.,21-Trihydroxypregna-1,4-diene-3,20-dione;P0637;HYDROCORTISONE IMPURITY A [EP IMPURITY];Prednisone Acetate;Prednisolone (Predonine);Prednisolone (1.0 mg/mL in Methanol);PrednisTab;Prednisolona (INN-Spanish);Prednisolone anhydrous Micronized;CS-0695025;NS00000394;Prednisolone (Standard);Prednisolonum (INN-Latin);1-Dehydrocortisol;HY-17463R;11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione;Prednisolone oral;(11?)-11,17,21-Trihydroxy-pregna-1,4-diene-3,20-dione;Metacortandralone;Delta F;(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one;200-021-7;FP27131;US10196374, Prednisolone;

MFCD00003649

OIGNJSKKLXVSLS-VWUMJDOOSA-N

1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1

O[C@]1(C(CO)=O)CC[C@H]2[C@@H]3CCC4=CC(C=C[C@]4(C)[C@H]3[C@H](C[C@@]21C)O)=O

200-021-7

2937229000

1354103